Education
About Us
Working with TipRanks
Follow Us
Memphasys Ltd (AU:MEM)
:MEM
MEM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.01
Previous CloseN/A
Volume7.30M
Average Volume (3M)6.43M
Market Cap
AU$7.93M
Enterprise ValueAU$16.27M
Total Cash (Recent Filing)AU$516.27K
Total Debt (Recent Filing)AU$4.30M
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,983,598,100
10 Day Avg. Volume10,733,247
30 Day Avg. Volume6,428,983
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Memphasys Ltd News
MEM FAQ
What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
What is Memphasys Ltd’s market cap?
Memphasys Ltd’s market cap is AU$7.93M.
When is Memphasys Ltd’s upcoming earnings report date?
Memphasys Ltd’s upcoming earnings report date is Aug 27, 2025 which is in 19 days.
How were Memphasys Ltd’s earnings last quarter?
Memphasys Ltd released its earnings results on Feb 28, 2025. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Memphasys Ltd overvalued?
According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued.
Does Memphasys Ltd pay dividends?
Memphasys Ltd does not currently pay dividends.
What is Memphasys Ltd’s EPS estimate?
Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Memphasys Ltd have?
Memphasys Ltd has 1,983,598,100 shares outstanding.
What happened to Memphasys Ltd’s price movement after its last earnings report?
Memphasys Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Memphasys Ltd?
Currently, no hedge funds are holding shares in AU:MEM
Memphasys Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:MEM Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-80.47%
Trailing 12-Months
Asset Growth
-16.41%
Trailing 12-Months
Company Description
Memphasys Ltd
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.
Living Cell Technologies
―
Regeneus Ltd.
―
Avecho Biotechnology Limited
―
AdAlta Ltd.
―
Chimeric Therapeutics Ltd.
―